Business Name: |
Institute-Addiction Medicine |
Contact Person: |
Joseph Volpicelli, Owner |
Address: |
1000 Germantown Pike # H2, Plymouth Meeting, Pennsylvania 19462 |
Phone Number: |
(484) 351-8031 |
Website Address: |
ioam.org |
Annual Revenue (USD): |
Unknown |
Founding Year: |
2008 |
Location Type: |
Single Location |
Employee Number: |
1 to 4 |
Business Type: |
B2C (Business to Consumer) |
Business Category: |
Health Services |
SIC Code: |
8099 |
NAICS Code: |
8133190 |
Share This Business: |
|
Related Businesses: |
Medical Literacy Works LLC - Plymouth Meeting, PA 19462 Matria Healthcare - Plymouth Meeting, PA 19462 United Healthcare - Plymouth Meeting, PA 19462 Women's Associates-Health Care - Plymouth Meeting, PA 19462 Green Earth Gardening LLC - Plymouth Meeting, PA 19462 Wissahickon Martial Arts And Wellness Center LLC - Plymouth Meeting, PA 19462 Health Advocate - Plymouth Meeting, PA 19462 Lavenders Body Care Clinic - Plymouth Meeting, PA 19462 General Health Care Resources - Plymouth Meeting, PA 19462 Delmarva Foundation-Medical Cr - Plymouth Meeting, PA 19462 I M S Health Inc - Plymouth Meeting, PA 19462 Patriot Health Care - Plymouth Meeting, PA 19462 Kim's Garden Of Wellness - Plymouth Meeting, PA 19462 |
The company Institute-Addiction Medicine provides B2C services in the form of Health Services from its single location in Pennsylvania.
1 to 4 employees work for Institute-Addiction Medicine, and the business now earns Unknown per annum.
Institute-Addiction Medicine was launched in 2008 and is classified under SIC code and category 8099 , and NAICS number and grouping 8133190 .
To contact Institute-Addiction Medicine, please call Joseph Volpicelli, Owner with the phone number (484) 351-8031 or visit its single location at 1000 Germantown Pike # H2 in Plymouth Meeting, Pennsylvania 19462.
The location of the single location can also be found using the coordinates 40.124343,-75.292316.
Read more details about this business on the webpage ioam.org or follow the company’s social media accounts, on Twitter and on Facebook.